1. Basic HPLC Concepts

Q1: What is HPLC and why is it preferred in pharmaceutical QC?

HPLC (High Performance Liquid Chromatography) is an analytical technique used to separate, identify, and quantify components in a mixture. In pharmaceutical QC, it's preferred because:

  • High sensitivity and accuracy for active pharmaceutical ingredients (APIs)
  • Ability to analyze thermally unstable compounds
  • Excellent reproducibility for regulatory compliance
  • Can handle complex matrices like tablets, capsules, and injections
  • Validated methods for pharmacopeial monographs (USP, BP, IP)
Q2: Differentiate between isocratic and gradient elution.

Isocratic elution: Constant mobile phase composition throughout the run.

Gradient elution: Mobile phase composition changes during the run (usually increasing organic solvent).

Parameter Isocratic Gradient
Mobile Phase Constant composition Changing composition
Best For Simple mixtures, QC of known compounds Complex mixtures, method development
Peak Shape May show tailing for late eluters Sharper peaks throughout
Run Time Longer for complex mixtures Shorter for complex mixtures
Q3: Explain the principle of reversed-phase chromatography.

Reversed-phase chromatography (RPC) is the most common HPLC mode where:

  • Stationary phase: Non-polar (C18, C8, C4, phenyl)
  • Mobile phase: Polar (water + organic solvent like methanol or acetonitrile)
  • Principle: Separation based on hydrophobicity - more hydrophobic compounds have stronger interaction with stationary phase and elute later
  • Elution order: Polar compounds elute first, non-polar compounds elute last

Pharmaceutical QC Application: 80-90% of pharmaceutical analyses use RPC because most APIs are organic compounds with varying hydrophobicity.

Q4: What is retention time (tᵣ) and why is it important?

Retention time (tᵣ) is the time taken for a compound to travel from injector to detector.

tᵣ = tₘ + tₛ

where tₘ = time in mobile phase, tₛ = time in stationary phase

Importance in QC:

  • Qualitative analysis: Identification by comparing with standard
  • System suitability: Check column performance and system stability
  • Method specificity: Ensure separation from impurities/degradants
  • USP requirements: Relative retention time (RRT) for impurity profiling

Calculation Example:

If solvent peak appears at 1.2 min and API peak at 8.5 min, then:

Retention time of API = 8.5 min

Relative retention time (vs internal standard at 6.0 min) = 8.5/6.0 = 1.42

2. HPLC Instrumentation & Components

Q5: Describe the main components of HPLC system.
  1. Solvent Reservoir: Holds mobile phase (degassed)
  2. Pump: Delivers constant flow rate (0.1-10 mL/min) at high pressure (up to 6000 psi)
  3. Injector: Introduces sample (manual or autosampler, 1-100 μL)
  4. Column: Heart of system where separation occurs (C18, 150×4.6 mm, 5 μm common)
  5. Detector: Measures eluted compounds (UV/VIS most common)
  6. Data System: Controls instrument and processes data
  7. Column Oven: Maintains constant temperature (often 25-40°C)
Q6: What are the different types of HPLC detectors?
Detector Principle Applications in Pharma QC Sensitivity
UV/VIS Absorption of light Most APIs (have chromophores) ng level
PDA/DAD Full spectrum acquisition Purity check, peak identity confirmation ng level
RID Refractive index change Sugars, polymers (no UV absorption) μg level
FLD Fluorescence emission Compounds with natural fluorescence (vitamins) pg level
ELSD Light scattering after nebulization Lipids, carbohydrates, impurities ng level
CAD Charged aerosol detection Universal detection for non-volatiles ng level
MS Mass-to-charge ratio Structural confirmation, impurity profiling pg level
Q7: How do you select appropriate column for pharmaceutical analysis?

Column selection criteria for pharma QC:

  1. Stationary phase: C18 for most APIs, C8 for larger molecules, phenyl for aromatic compounds
  2. Particle size: 5 μm for routine, 3.5 μm for faster analysis, 1.8 μm for UHPLC
  3. Column dimensions: 150×4.6 mm standard, 50×4.6 mm for fast LC, 250×4.6 mm for complex separations
  4. Manufacturer: Use column specified in method (USP often specifies L1, L7, etc.)
  5. pH range: Standard (2-8) or extended pH (1-12) based on mobile phase

QC Tip: Always use same column brand and lot mentioned in validated method. Column equivalency requires re-validation.

3. HPLC Calculations & Mathematics

Q8: Calculate column efficiency (theoretical plates, N).

Theoretical plates (N) measure column efficiency. Higher N = better efficiency.

N = 16 × (tᵣ/w)² = 5.54 × (tᵣ/w₁⸍₂)²

where: tᵣ = retention time, w = peak width at baseline, w₁⸍₂ = peak width at half height

Calculation Example:

A peak has retention time = 10.2 min, width at baseline = 0.8 min

N = 16 × (10.2/0.8)² = 16 × (12.75)² = 16 × 162.56 = 2601 plates

USP typically requires N > 2000 for main peak in system suitability.

Q9: Calculate resolution (Rₛ) between two peaks.

Resolution (Rₛ) measures separation between two adjacent peaks.

Rₛ = 2 × (tᵣ₂ - tᵣ₁) / (w₁ + w₂)

where: tᵣ₁, tᵣ₂ = retention times of peaks 1 and 2, w₁, w₂ = peak widths at baseline

Calculation Example:

Peak 1: tᵣ = 8.5 min, w = 0.5 min

Peak 2: tᵣ = 9.2 min, w = 0.6 min

Rₛ = 2 × (9.2 - 8.5) / (0.5 + 0.6) = 2 × 0.7 / 1.1 = 1.4 / 1.1 = 1.27

Interpretation: Rₛ ≥ 1.5 = baseline separation (USP requirement for critical pair)

Q10: Calculate tailing factor (T) and its importance.

Tailing factor (T) measures peak symmetry. T = 1 for perfect Gaussian peak.

T = w₀.₀₅ / (2 × f)

where: w₀.₀₅ = peak width at 5% height, f = distance from peak front to peak maximum at 5% height

Calculation Example:

If peak width at 5% height = 1.2 min and distance from front to max = 0.5 min:

T = 1.2 / (2 × 0.5) = 1.2 / 1.0 = 1.2

USP limits: T should be 0.9-1.2 for main peak in system suitability.

High tailing (>1.5) indicates: Column degradation, secondary interactions, wrong pH, or overloading.

Q11: Calculate assay percentage of API in tablet.

Assay calculation for tablets:

% Assay = (Aₛₐₘₚₗₑ/Aₛₜₐₙₖ) × (Cₛₜₐₙₖ/Cₜₕₑₒᵣ) × (Dₛₐₘₚₗₑ) × (Avg. Wt./Label Claim) × 100 × P

where: A = peak area, C = concentration, D = dilution factor, P = purity of standard

Calculation Example:

Paracetamol 500 mg tablet analysis:

  • Std conc: 0.1 mg/mL, Std area: 150000
  • Sample area: 148500 (after dilution to 0.1 mg/mL)
  • Avg tablet weight: 600 mg, Label claim: 500 mg
  • Standard purity: 99.5%

% Assay = (148500/150000) × (0.1/0.1) × 1 × (600/500) × 100 × 0.995

= 0.99 × 1 × 1 × 1.2 × 100 × 0.995 = 118.2%

Acceptance criteria: Typically 90-110% of label claim for tablets.

Q12: Calculate related substances/impurities percentage.

Impurity calculation:

% Impurity = (Aᵢ/Aₛ) × (Cₛ/Cᵢ) × (1/RRFᵢ) × 100

where: Aᵢ = impurity peak area, Aₛ = API peak area, Cₛ = API concentration, Cᵢ = impurity concentration (if external std), RRFᵢ = relative response factor

Calculation Example (Area Normalization):

Total areas: API = 1,000,000, Impurity A = 5,000, Impurity B = 2,000

% Impurity A = (5000/1000000) × 100 = 0.5%

% Impurity B = (2000/1000000) × 100 = 0.2%

Total impurities = 0.7% (must be < 1.0% as per ICH Q3A)

Q13: Calculate signal-to-noise ratio (S/N) for LOD/LOQ determination.

Signal-to-noise ratio (S/N):

S/N = Hₚ / Hₙ

where: Hₚ = peak height, Hₙ = noise height (peak-to-peak)

Calculation Example:

Peak height = 15 mm, Noise (peak-to-peak) = 2 mm

S/N = 15 / 2 = 7.5

ICH Guidelines:

  • LOD (Limit of Detection): S/N ≥ 3
  • LOQ (Limit of Quantification): S/N ≥ 10

4. Troubleshooting & Maintenance

Q14: What causes high backpressure and how to resolve it?

Causes of high backpressure:

  1. Column blockage (particulate matter)
  2. Mobile phase filter blockage
  3. Column temperature too low
  4. High viscosity mobile phase
  5. Small particle size column at high flow

Troubleshooting steps:

  1. Check pressure against new column (baseline)
  2. Replace inlet frit or guard column
  3. Flush column with appropriate solvent
  4. Filter mobile phase through 0.45 μm membrane
  5. Check for leaks in system

Prevention: Always filter samples (0.45 μm), use guard column, degas mobile phase, avoid pH extremes.

Q15: What causes peak tailing and how to fix it?

Causes and solutions for peak tailing:

Cause Solution
Column degradation Replace column, use within pH range
Secondary interactions (silanol) Add TEA, use endcapped column
Overloading Reduce injection volume/concentration
Wrong pH for ionizable compound Adjust pH 2 units away from pKa
Void at column inlet Replace column or refill inlet
Extra-column volume Check tubing connections, reduce volume
Q16: How do you perform HPLC system qualification?

HPLC System Qualification (as per GMP):

  1. Design Qualification (DQ): Select appropriate instrument
  2. Installation Qualification (IQ): Verify installation as per specs
  3. Operational Qualification (OQ): Verify performance parameters:
    • Pump: Flow accuracy/precision (±1%)
    • Injector: Precision (RSD < 1%), carryover (< 0.1%)
    • Detector: Linearity (r² > 0.999), wavelength accuracy (±2 nm)
    • Column oven: Temperature accuracy (±1°C)
  4. Performance Qualification (PQ): System suitability test with reference standard

5. Pharmaceutical QC Specific Questions

Q17: What is system suitability test (SST) and its parameters?

System Suitability Test (SST) verifies system performance before sample analysis.

Parameter Acceptance Criteria (Typical) Importance
Theoretical plates (N) > 2000 Column efficiency
Tailing factor (T) 0.9 - 1.5 Peak symmetry
Resolution (Rₛ) > 1.5 (critical pair) Separation
Precision (RSD of replicates) < 2% System precision
Retention time (RSD) < 1% System stability
Signal-to-noise (S/N) > 10 for LOQ level Sensitivity

GMP Requirement: SST must pass before and during sample analysis (typically after every 6-12 injections).

Q18: Explain ICH guidelines for method validation in HPLC.

ICH Q2(R1) Validation Parameters:

  1. Specificity: Ability to measure analyte in presence of impurities/degradants
  2. Linearity: r² > 0.999 (80-120% of target concentration)
  3. Accuracy: Recovery 98-102% (spiked samples)
  4. Precision:
    • Repeatability (intra-day): RSD < 2%
    • Intermediate precision (inter-day, different analyst): RSD < 3%
  5. Range: 80-120% of test concentration
  6. Detection Limit (LOD): S/N ≥ 3
  7. Quantitation Limit (LOQ): S/N ≥ 10, precision RSD < 10%
  8. Robustness: Small deliberate changes in method parameters
Q19: How do you handle out-of-specification (OOS) results in HPLC analysis?

OOS Investigation Procedure (as per FDA guidelines):

  1. Phase I - Laboratory Investigation:
    • Check calculation errors
    • Verify standard/sample preparation
    • Check instrument performance (SST)
    • Review chromatograms for anomalies
    • Retest original sample preparation if justified
  2. Phase II - Full Scale Investigation:
    • Extend investigation to manufacturing
    • Test additional samples from batch
    • Root cause analysis (5 Whys, Fishbone)
  3. Phase III - Conclusion:
    • Document all findings
    • Implement CAPA (Corrective and Preventive Actions)
    • Final disposition of batch

Critical: Never discard OOS results without investigation. All investigations must be documented.

Q20: Describe forced degradation studies for method validation.

Forced Degradation (Stress Testing):

  1. Acid hydrolysis: 0.1N HCl, room temp/60°C, 24 hours
  2. Base hydrolysis: 0.1N NaOH, room temp/60°C, 24 hours
  3. Oxidative: 3% H₂O₂, room temp, 24 hours
  4. Thermal: 60°C (solid), 40°C (solution), 2 weeks
  5. Photolytic: UV light (ICH Q1B), 200 watt-hr/m²
  6. Humidity: 75% RH, 25°C, 2 weeks

Acceptance Criteria:

  • Mass balance: 98-102% (degradants + remaining API)
  • Peak purity: > 990 match factor (PDA)
  • No co-elution of degradants with API
  • Method should resolve all degradants